EpiVax
company
About
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $300K
- Industries
- Analytics,Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
7
$4.21M
EpiVax has raised a total of
$4.21M
in funding over 2 rounds. Their latest funding was raised on
Sep 12, 2016 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 12, 2016 | Grant | $600K | 1 |
National Institutes of Health
|
— | Detail |
| Sep 5, 2012 | Grant | $300K | 1 |
National Institutes of Health
|
— | Detail |
| Apr 9, 2012 | Grant | $1.50M | 1 | — | — | Detail |
| Jan 25, 2011 | Grant | $458K | 1 | — | — | Detail |
| Nov 26, 2008 | Grant | $390K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
EpiVax is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
